Mounjaro 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV7P6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,344
Award facts
- Contract value 100% obligated
- $12,343.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $12,343.87 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pens on January 12, 2026, with completion scheduled for January 13, 2026. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a subsidiary of parent company Cencora, Inc., and serves as a critical pharmaceutical distributor for federal medical procurement. The delivery order is issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which is valued at up to $999,999,999.00 and extends through December 2026, enabling comprehensive global pharmaceutical support for military healthcare programs.
This delivery order represents a routine pharmaceutical supply transaction supporting the Defense Health Agency and other military healthcare systems. AmerisourceBergen Drug Corp maintains substantial federal contracting capacity through its parent company Cencora, Inc., which holds multiple high-value IDCs with federal agencies including the DLA and Department of Veterans Affairs. The supply of Mounjaro, a diabetes medication, aligns with the company's established portfolio of delivering specialty medications and brand-name pharmaceuticals across multiple therapeutic domains to support military treatment facilities and veterans' healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FV7P6?
SPE2DR26FV7P6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FV7P6 worth?
The government has obligated $12,344 on SPE2DR26FV7P6.
Is contract SPE2DR26FV7P6 an order under another contract?
Yes. SPE2DR26FV7P6 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7P6 competed?
The extent of competition for SPE2DR26FV7P6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award